The findings from AD mouse models for FSH blockade as well as beneficial effect of FSH blockade on bone mass show a promise for exploring FSH either as a standalone therapy for targeting both osteoporosis and ADRD or in combination with estrogen replacement therapy in post-menopausal women. This evidence concerns the gene BRD2 and Alzheimer disease.